GeoVax Labs, Inc. has entered into agreements to sell 1,360,731 shares of common stock at $5.00 each and pre-funded warrants for 339,269 shares, raising approximately $7.86 million for working capital. The offering closed on August 21, 2024, with restrictions on future stock issuance for a specified period.